The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Negasheva E.S.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Vasiltsova M.Yu.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Frigo N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Gushchin A.E.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dolya O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Peoples’ Friendship University of Russia

Kitaeva N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Mardanli S.G.

State University of Humanities and Technology (GGTU)

Zatorskaya N.F.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Laboratory diagnosis of «key» sexually transmitted infections. Part II

Authors:

Negasheva E.S., Vasiltsova M.Yu., Frigo N.V., Gushchin A.E., Dolya O.V., Kitaeva N.V., Mardanli S.G., Zatorskaya N.F.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2024;23(1): 6‑11

DOI: 10.17116/klinderma2024230116

Read: 2152 times

Download PDF (RU)
Contact the author
Table of contents

LABORATORY DIAGNOSIS OF «KEY» SEXUALLY TRANSMITTED INFECTIONS. PART II
LABORATORY DIAGNOSIS OF «KEY» SEXUALLY TRANSMITTED INFECTIONS. PART II

To cite this article:

Negasheva ES, Vasiltsova MYu, Frigo NV, et al. . Laboratory diagnosis of «key» sexually transmitted infections. Part II. Russian Journal of Clinical Dermatology and Venereology. 2024;23(1):6‑11. (In Russ.)
https://doi.org/10.17116/klinderma2024230116

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Retrospective analysis of sexually transmitted infe­ctions inci­dence in countries of the world. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):132-142
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Resu­lts of the All-Russian consensus conference on complications in bariatric surgery. Endo­scopic Surgery. 2025;(1):15-24
X-ray endo­scopic classification of aspi­ration syndrome. Endo­scopic Surgery. 2025;(1):31-37
Virus-associated progesterone-resistant chro­nic endo­metritis — the onco­risk situation?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):25-30
Acute kidney injury during pregnancy with favo­rable obstetric and nephrological outcome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):65-70
Arti­ficial Inte­lligence in Dentistry: A Sign of the Times. Stomatology. 2025;(1):87-92
Reproductive health of women with hepa­titis C (literature review and own data). Russian Journal of Human Reproduction. 2025;(1):12-20
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
Primary bile acid synthesis diso­rders. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):71-90
Abstract:

The review summarizes information on laboratory methods for the diagnosis of sexually transmitted infections (STIs) prevalent in the Russian Federation caused by bacterial and protozoan pathogens, namely T. vaginalis and M. genitalium. The estimation and location of each method in the diagnosis of these infections were given. It was shown that the absolute priority in the diagnosis of infections caused by T. vaginalis and M. genitalium are direct methods of identification, among which preference is currently given to molecular biological methods with high sensitivity and specificity, rapid results (compared to the culture method) without the presence of a living agent that allows the simultaneous identification of several pathogens in one sample of biomaterial and quantification DNA/RNA pathogens (Real-time PCR). The nucleic acid amplification technique (NAAT) for simultaneous identification of 4 «key» STIs pathogens (N. gonorrhoeae, C. trachomatis, M. genitalium, T. vaginalis), which increases the effectiveness of diagnosis of these infections, has been noted to be extremely popular in modern conditions. In addition, the clinical material for the study in NAAT in men is the first portion of urine, the urethral discharge, in women — the discharge from urethra, cervical canal, the first portion of urine.

Keywords:

sexually transmitted infections
diagnosis
M.genitalium
T.vaginalis
N.gonorrhoeae
C.trachomatis
molecular biological methods
NAAT

Authors:

Negasheva E.S.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Vasiltsova M.Yu.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Frigo N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Gushchin A.E.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dolya O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Peoples’ Friendship University of Russia

Kitaeva N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Mardanli S.G.

State University of Humanities and Technology (GGTU)

Zatorskaya N.F.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Received:

09.03.2023

Accepted:

16.11.2023

Close metadata

References:

  1. Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, Fleischmann RD, Bult CJ, Kerlavage AR, Sutton G, Kelley JM, Fritchman RD, Weidman JF, Small KV, Sandusky M, Fuhrmann J, Nguyen D, Utterback TR, Saudek DM, Phillips CA, Merrick JM, Tomb JF, Dougherty BA, Bott KF, Hu PC, Lucier TS, Peterson SN, Smith HO, Hutchison 3rd CA, Venter JC. The minimal gene complement of Mycoplasma genitalium. Science. 1995;270(5235):397-403. 
  2. Shipicyna EV, Savicheva AM, Ben’kovich AS, Sokolovskij EV. Mycoplasma genitalium as a causative agent of infections of the urogenital tract: pathogenesis, clinic, diagnosis and treatment. Zhurnal’ akusherstva i zhenskix’ boleznej. 2008;2:111-120. (In Russ.).
  3. Jensen JS. Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis. Copenhagen 2005.
  4. Manhart LE, Critchlow CW, Holmes KK. Mucopurulent cervicitis and Mycoplasma genitalium. J of Inf Dis. 2003;187:650-657. 
  5. Cohen CR, Manhart LE, Bukusi AS. Association between Mycoplasma genitalium and acute endometritis. Lancet. 2002;359:765-766. 
  6. Oakeshott P, Hay P, Taylor-Robinson D, Hay S, Dohn B, Kerry S, Jensen JS. Prevalence of Mycoplasma genitalium in early pregnancy and the relationship between its presence and pregnancy outcome. Br J Obstet Gynaecol. 2004;111(12):1464-1467.
  7. Urogenital’ny’e zabolevaniya, vy’zvanny’e Mycoplasma genitalium. Klinicheskie rekomendacii 2021. (In Russ.). Accessed Mars 03, 2023. https://cr.minzdrav.gov.ru/schema/216_1
  8. CDC’s Sexually Transmitted Infections (STI) Treatment Guidelines 2021; Mycoplasma genitalium; Accessed Mars 03, 2023. https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm
  9. Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad of Dermatol and Venereol. 2016; 30(10):1650-1656. https://doi.org/10.1111/jdv.13849
  10. Yoshida T, Deguchi T, Ito M, Maeda S-I, Tamaki M, Ishiko H. Quantitative detection of Mycoplasma genitalium from firstpass urine of men with urethritis and asymptomatic men by real-time PCR. J Clin Microbiol. 2002; 40(4):1451-1455.
  11. Baseman JB, Cagle M, Korte JE, Herrera C, Rasmussen WG, Baseman JG, Shain R, Piper JM. Diagnostic assessment of Mycoplasma genitalium in culturepositive women. J Clin Microbiol. 2004;42(1):203-211. 
  12. Jensen JS, Hansen HT, Lind K. Isolation of Mycoplasma genitalium strains from the male urethra. J Clin Microbiol. 1996;34:286-291. 
  13. Lind K. Serological cross-reactions between Mycoplasma genitalium and M. pneumonia. Lancet. 1982;2(8308):1158-1159.
  14. Jensen JS. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene. Methods Mol Biol. 2012;903:129-139.  https://doi.org/10.1007/978-1-61779-937-2_8
  15. Touati A, Peuchant O, Jensen JS, Bebear C, Pereyre S. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol. 2014;52:1549-1555.
  16. Wold C, Sorthe J, Hartgill U, Olsen AO, Moghaddam A, Reinton N. Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR. J Eur Acad Dermatol Venereol. 2015;29(8):1616-1620.
  17. E’jdel’shtejn IA, Rudneva NS, Romanov AV, Zubareva LM, Kuz’menkov AYu, Kolesnikova EA, Trushin IV, Borisov IV, Suxanova LN, Axmedova AM, Novikova OP, Kozlov RS. Monitoring of macrolide resistance-associated mutations in Mycoplasma genitalium in Russia. Klinicheskaya mikrobiologiya i antimikrobnaya ximioterapiya. 2022;1(24):52-60. (In Russ.). https://doi.org/10.36488/cmac.2022.1.52-60
  18. Romanova IV. Sovershenstvovanie vedeniya bol’nyh Mycoplasma genitalium-infekciej na osnovanii rezul’tatov izucheniya geneticheskih markerov rezistentnosti vozbuditelya k antibakterial’nym preparatam: dissertaciya... kandidata medicinskih nauk. M. 2020. (In Russ.).
  19. Richter SS, Patel JB. Mechanisms of Resistance to Antibacterial Agents. In: Manual of Clinical Microbiology, 11th Edition. American Society of Microbiology. 2015;1212-1245. https://doi.org/10.1128/9781555817381.ch69
  20. Deguchi T, Ito S, Yasuda M, Sato Y, Uchida C, Sawamura M, Manda K, Takanashi M, Kiyota H. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. J Infect Chemother. 2018;24(11):861-867. 
  21. Romanova IV, Kisina VI, Khayrullina GA, Frigo NV, Zhukova OV, Gushchin AE. The prevalence and type of mutations of in dermatovenereological patients from the Moscow region for 2014‒2018. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2020;19(1):7-12. (In Russ.). https://doi.org/10.17116/klinderma2020190117
  22. Resursy i deyatel’nost’ medicinskih organizacij dermatovenerologicheskogo profilya. Zabolevaemost’ infekciyami, peredavaemymi polovym putem, zaraznymi kozhnymi boleznyami i zabolevaniyami kozhi za 2020—2021 gody. Statisticheskie materialy. M. 2022. (In Russ.).
  23. Fedina ED, Baxirev DE, Kolkova NI, Zigangirova NA. lymphogranuloma venereum: epidemic of the old disease in new regions. Klin mikrobiol antimikrob ximioter. 2013;4(15):261-269. (In Russ.).
  24. Tyulenev YA, Guschin AE, Titov IS, Frigo NV, Potekaev NN, Unemo M. First reported lymphogranuloma venereum cases in Russia discovered in men who have sex with men attending proctologists. Int J STD AIDS. 2022;5(33):456-461. 
  25. Gomberg MA, D’yakonov SA, Raevskaya OA. Legal conflicts in the diagnosis of diseases accompanied by pathological secretions from the genital tract of women. StatusPraesens. Ginekologiya, akusherstvo, besplodnyj brak. 2021;2(76):41-47. (In Russ.).
  26. Silver BJ, Guy RJ, Kaldor JM, Jamil MS, Rumbold AR. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41(6):369-376. 
  27. Urogenital’ny’j trixomoniaz. Klinicheskie rekomendacii 2021. Accessed Mars 03, 2023. (In Russ.). https://cr.minzdrav.gov.ru/schema/241_2
  28. Madico G, Quinn TC, Rompalo A, McKee Jr KT, Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol. 1998;36:3205-3210.
  29. Mayta H, Gilman RH, Calderon MM, Gottlieb A, Soto Gtuero I, Sanchez S, Vivar A. 18S ribosomal DNA-based PCR for the diagnosis of Trichomonas vaginalis. J Clin Microbiol. 2000;38:2683-2687.
  30. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. American Journal of Obstetrics and Gynecology. 2009;200(2): 188.e1-7.  https://doi.org/10.1016/j.ajog.2008.10.005
  31. Schwebke JR, Hobbs MM, Taylor SN, Sena AC, Catania MG, Weinbaum BS, Johnson AD, Getman DK, Gaydos CA. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol. 2011;49(12):4106-4111.
  32. Cosentino LA, Campbell T, Jett A, Macio I, Zamborsky T, Cranston RD, Hillier SL. Use of nucleic acid amplification testing or diagnosis of anorectal sexually transmitted infections. J Clin Microbiol. 2012;50(6):2005-2008.
  33. Jackie Sherrard, Janet Wilson, Gilbert Donders, Werner Mendling4 and Jørgen S Jensen. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018; 29(13):1258-1272. https://doi.org/10.1177/0956462418785451
  34. Bickley LS, Krisher KK, Punsalang A, Trupei MA, Reichman RC, Menegus MA. Comparison of direct fluorescent antibody, acridine orange, wet mount and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted disease clinic. Sex Trans Dis. 1989;16(3): 127-131. 
  35. Hobbs MM, Lapple DN, Lawing LF, Schwebke JR, Cohen MS, Swygard H, Atashili J, Leone PA, Miller WC, Seña AC. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. Journal of Clinical Microbiology. 2006;44:3994-3999.
  36. Adjei C, Boateng R, Dompreh A, Okyere B, Owiredu E-W. Prevalence and the evaluation of culture, wet mount, and ELISA methods for the diagnosis of Trichomonas vaginalis infection among Ghanaian women using urine and vaginal specimens. Trop Med Health. 2019;47:33.  https://doi.org/10.1186/s41182-019-0162-9
  37. CDC’s Sexually Transmitted Infections (STI) Treatment Guidelines 2021; Accessed Mars 03, 2023. https://www.cdc.gov/std/treatment-guidelines/gonorrhoea.htm
  38. Campbell L, Woods V, Lloyd T, Elsayed S, Church DL. Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J Clin Microbiol. 2008;46:3467-3469. https://doi.org/10.1128/JCM.00671-08
  39. Huppert JS, Hesse E, Kim G, Kim M, Agreda P, Quinn N, Gaydos C. Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex Transm Infect. 2010;86(7):514-519.  https://doi.org/10.1136/sti.2009.042168
  40. Gaydos CA, Schwebke J, Dombrowski J, Marrazzo J, Coleman J, Silver B, Barnes M, Crane L, Fine P. Clinical performance of the Solana Point-of-Care Trichomonas Assay from cliniciancollected vaginal swabs and urine specimens from symptomatic and asymptomatic women. Expert Rev Mol Diagn. 2017;17(3):303-306.  https://doi.org/10.1080/14737159.2017.1282823
  41. Gaydos CA, Hobbs M, Marrazzo J, Schwebke J, Coleman JS, Masek B, Dize L, Jang D, Li J, Chernesky M. Rapid diagnosis of Trichomonas vaginalis by testing vaginal swabs in an isothermal helicase-dependent AmpliVue Assay. Sex Transm Dis. 2016;43:369-373.  https://doi.org/10.1097/OLQ.0000000000000447
  42. Gushchin AE, Ryzhikh PG, Savochkina IuA, Shipulina OIu, Shipulin GA. Investigation the prevalence of the causative agents of STI (C. trachomatis, N. gonorrhoeae, M. genitalium, T. vaginalis) by real-time PCR using the MULTIPRIME system. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2011;9(4):90-94. (In Russ.).
  43. Dmitryukova MYu, Senina ME, Surovcev VV, Gushhin AE. Diagnosis of Pathogenic Microorganisms of the Vaginal Microbiota by Real-Time Quantitative PCR Method. Trudny’j pacient. 2019;8-9(17):7-9. (In Russ.). https://doi.org/10.24411/2074-1995-2019-10054
  44. Potekaev NN, Negasheva ES, Guschin AE, Polevshchikova SA, Frigo NV, Dmitriev GA. Experience of the Moscow Scientific and Practical Center for Dermatovenerology and Cosmetology in using a novel multiplex PCR test for STIs. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2022;21(5):619-628. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.